Not provided
Not provided
Not provided
Not provided
CV-19 pandemic
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Public Health Wales | OTHER_GOV |
| Cwm Taf University Health Board (NHS) | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Prescribing lifestyle changes to patients who have cardiovascular disease (CVD) may be an extremely cost effective mechanism of improving health individually and for the NHS. Positive lifestyle changes such as improved diet, increased physical activity, quitting smoking and reducing alcohol consumption have been proven to reform the health status of individuals with CVD. S-PLAC 2 is a phase II study to determine the efficacy of a lifestyle prescription (L℞) in patients and healthcare practitioners in a secondary care setting (i.e. hospital clinics/wards).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control (Standard Care) | No Intervention | Standard care during consultations. Advice and guidance offered by clinicians verbally and sometimes the addition of leaflets or a referral. | |
| Intervention (Standard Care plus Lifestyle prescription - LRx) | Experimental | Standard care during consultations with the addition of a physical lifestyle prescription. Advice and guidance will be offered by clinicians verbally, whilst being supported with a lifestyle prescription and a possible referral if required. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Lifestyle Prescription (LRx) | Behavioral | Standard care during consultations with the addition of a physical lifestyle prescription |
|
| Measure | Description | Time Frame |
|---|---|---|
| A prescription (LRx) being issued during a consultation | Number of so-signed prescription (LRx) forms. Total number of forms to be co-signed = 60 | During month 7 of the study |
| Patient view of the prescription (LRx) and consultation Questionnaire | Completed study questionnaires. Total number of questionnaires to be completed = 120. Responses will be recorded to gain feedback from the patient participants regarding their thoughts and feelings of their consultation with and without the intervention of the prescription (LRx). Scale: 7 (minimum) to 41 (maximum). A lower value represents a better (more positive) outcome. | During month 7 of the study |
| Healthcare practitioner (HCP) view of the prescription (LRx) and consultation questionnaire. | Completed clinician questionnaire. Total number of questionnaires to be completed = 6. Responses will be recorded to gain feedback from the clinicians regarding their thoughts and feelings of their consultations with and without the intervention of the prescription (LRx). Sections: Section 1 scale: 9 to 54 (a lower score represents a better, more positive outcome) Section 2 scale: 8 to 48 (a lower score represents a better, more positive outcome) Section 3 scale: 6 to 36 (a lower score represents a better, more positive outcome) Total score available: 23 to 138 | During month 7 of the study |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of South Wales | Pontypridd | United Kingdom |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
| D015438 | Health Behavior |
| ID | Term |
|---|---|
| D001519 | Behavior |
Not provided
Not provided
The study is an interventional controlled observational study based in the Secondary care setting. Control groups will be utilized through the mechanism of wait-listing the enrolment of recruitment centres into the study.
Mixed methods will be used for both data collection and analysis. Historical clinical participant data (pre-intervention) will be collected by the PI. data will be collected immediately after the consultation and at 3 months post intervention.
Not provided
Not provided
Not provided
Not provided